1.3403
0.74%
-0.0097
Why is Generation Bio Co (GBIO) Stock down?
We've noticed a 7.14% decline in Generation Bio Co (GBIO) stock during the 2024-11-18 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
19 Oct, 2023:
Generation Bio Stock (GBIO) dropped by 50.21% from $2.41 to $1.20 in the trading on Thursday October 19, 2023. The reason why GBIO stock down today is due to the downgrade from analyst. TD Cowen downgraded the genetic medicines company to Market Perform from Outperform, citing a delay for the company’s lead program in hemophilia A. The downgrade comes after the Cambridge, Massachusetts-based biotech announced the development of a novel compound called immune-quiet DNA (iqDNA), which it expects to use in its lead hemophilia A program and other programs.
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):